Riverstone Advisors, LLC Merck & Co., Inc. Transaction History

Riverstone Advisors, LLC

$172 Million
Q3 2024

A detailed history of Riverstone Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Riverstone Advisors, LLC holds 4,169 shares of MRK stock, worth $416,316. This represents 0.28% of its overall portfolio holdings.

Number of Shares

4,169

Previous 4,169 -0.0%

Holding current value

$416,316

Previous $516,000 8.33%

% of portfolio

0.28%

Previous 0.32%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$113.24 - $131.95 $6,794 - $7,916	-60 Reduced 1.42%	4,169 $550,000
Q4 2023 Jan 30, 2024	SELL	$100.18 - $109.02 $11,019 - $11,992	-110 Reduced 2.54%	4,229 $461,000
Q2 2023 Aug 03, 2023	BUY	$108.61 - $118.38 $34,212 - $37,289	315 Added 7.83%	4,339 $500,000
Q2 2022 Jul 26, 2022	BUY	$83.49 - $94.64 $76,393 - $86,595	915 Added 29.43%	4,024 $367,000
Q1 2022 Apr 29, 2022	BUY	$73.51 - $82.4 $228,542 - $256,181	3,109 New	3,109 $255,000
Q4 2020 Feb 02, 2021	SELL	$71.77 - $79.65 $225,357 - $250,101	-3,140 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$70.42 - $80.13 $82,743 - $94,152	-1,175 Reduced 27.23%	3,140 $243,000
Q1 2020 Apr 29, 2020	SELL	$63.36 - $87.82 $1,267 - $1,756	-20 Reduced 0.46%	4,315 $332,000
Q4 2019 Jan 31, 2020	SELL	$77.58 - $87.54 $7,059 - $7,966	-91 Reduced 2.06%	4,335 $394,000
Q3 2019 Oct 25, 2019	BUY	$76.08 - $82.93 $131,618 - $143,468	1,730 Added 64.17%	4,426 $373,000
Q4 2018 Feb 15, 2019	BUY	$65.24 - $75.71 $175,887 - $204,114	2,696 New	2,696 $206,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverstone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverstone Advisors, LLC with notifications on news.

Account

Riverstone Advisors, LLC Merck & Co., Inc. Transaction History